Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses

Details for Australian Patent Application No. 2002316558 (hide)

Owner ABIC Biological Laboratories Teva Ltd.

Inventors Smith, Nicolas, C.; Belli, Sabina, I.; Wallach, Michael

Agent FB Rice

Pub. Number AU-B-2002316558

PCT Number PCT/US02/21233

PCT Pub. Number WO2003/004683

Priority 60/303,699 06.07.01 US

Filing date 3 July 2002

Wipo publication date 21 January 2003

Acceptance publication date 8 January 2009

International Classifications

A01K 67/02 (2006.01) Rearing or breeding animals, not otherwise provided for

A61K 39/002 (2006.01) Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 39/012 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 33/02 (2006.01) Antiparasitic agents

C07K 14/455 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/30 (2006.01) Mutation or genetic engineering - Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/303,699 06.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002316558

16 December 2004 Assignment before Grant

  Belli, Sabina; Smith, Nicolas; Wallach, Michael The application has been assigned to ABIC Biological Laboratories Teva Ltd.

8 January 2009 Alteration of Name

  The name of the applicant has been altered to ABIC Biological Laboratories Ltd

8 January 2009 Application Accepted

  Published as AU-B-2002316558

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316559-In situ process for preparing quaternary ammonium bicarbonates and quaternary ammonium carbonates

2002316557-NUCLEIC ACID REGULATORY SEQUENCES AND USES THEREOF